Condition
Carcinoma, Small Cell Lung clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Carcinoma, Small Cell Lung clinical trials that are recruiting, at sites in 12 countries (most in Spain (2), Australia (1), Brazil (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 12Countries
All recruiting trials (2)
-
PF-08634404 with or without chemotherapy for adults with transformed small cell lung cancer
This will try the experimental drug PF-08634404 by itself and together with chemotherapy in adults whose EGFR-mutated non-small cell lung cancer has turned into transformed small cell lung cancer.
-
Tarlatamab as maintenance treatment after chemo-radiotherapy for limited-stage small-cell lung cancer.
This trial will test whether giving tarlatamab after chemo-radiotherapy helps people with limited-stage small-cell lung cancer stay progression-free longer.
Related topics
Quick answers
How many Carcinoma, Small Cell Lung clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in Spain (2 trials), Australia (1 trial), Brazil (1 trial), China (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.